挪威东南部垂体手术后肢端肥大症的长期控制
该研究基于当地垂体登记库纳入2005—2020年因生长激素分泌型垂体腺瘤手术的178例肢端肥大症患者,评估术后1年与5年生化控制率。结果显示手术单独实现的生化控制在短期为53%、长期为41%,基线IGF-1水平可预测短期但非长期手术生化控制。
要点
- 手术单独生化控制率短期53%、长期41%,配对样本短期45% vs 长期41%(p=0.213)。
- 长期微腺瘤生化控制率58%、大腺瘤37%(p=0.058)。
- 辅助治疗后长期生化控制率达82%。
核心结论
- 在未选择的肢端肥大症患者中,长期生化控制率仍较有限,作者认为需在更早阶段识别患者并改进治疗方法和手术结局。
研究设计与样本
- 基于当地垂体登记库纳入2005—2020年因生长激素分泌型垂体腺瘤手术的肢端肥大症患者178例,中位诊断年龄49岁(IQR:38-59),女性46%。
主要发现
- 手术单独实现生化控制短期随访为53%、长期随访为41%。
- 配对样本中手术单独生化控制率短期45% vs 长期41%(p=0.213)。
- 短期随访微腺瘤生化控制率62%、大腺瘤51%;长期随访微腺瘤58%、大腺瘤37%(p=0.058)。
- 联合辅助治疗后长期生化控制率达82%。
- 基线IGF-1水平可预测短期手术生化控制(OR:0.98(95% CI:0.96-0.99),p=0.011),但长期未达统计学显著(OR:0.76(95% CI:0.57-1.00),p=0.053)。
关键数值与推荐
- 生化控制定义为胰岛素样生长因子1(IGF-1)≤1.2倍正常值上限。
- 采用多因素回归模型识别可能预测生化控制的因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Sustained cure of acromegaly can only be achieved by surgery. Most growth hormone (GH) secreting pituitary adenomas are macroadenomas (≥ 10 mm) at diagnosis, with reported surgical cure rates of approximately 50%. Long-term data on disease control rates after surgery are limited. Our aim was to estimate short- and long-term rates of biochemical control after pituitary surgery in acromegaly and identify predictive factors. METHODS: Patients operated for GH-secreting pituitary adenomas between 2005-2020 were included from the local pituitary registry (n = 178). Disease activity and treatment data were recorded at one-year (short-term) and five-year (long-term) postoperative follow-up. Biochemical control was defined as insulin-like growth factor 1 (IGF-1) ≤ 1.2 × upper limit of normal value. Multivariate regression models were used to identify factors potentially predicting biochemical control. RESULTS: A total of 178 patients with acromegaly (median age at diagnosis 49 (IQR: 38-59) years, 46% women) were operated for a pituitary adenoma. Biochemical control was achieved by surgery in 53% at short-term and 41% at long-term follow-up, without additional treatment for acromegaly. Biochemical control rates by surgery were of same magnitude in paired samples (45% vs. 41%, p = 0.213) for short- and long-term follow-up, respectively. At short-term, 62% of patients with microadenomas and 51% with macroadenomas, achieved biochemical control. At long-term, the biochemical control rate was 58% for microadenomas and 37% for macroadenomas (p = 0.058). With adjunctive treatment, 82% achieved biochemical control at long-term. Baseline IGF-1 levels significantly predicted biochemical control by surgery at short-term (OR: 0.98 (95% CI: 0.96-0.99), p = 0.011), but not at long-term (OR: 0.76 (95% CI: 0.57-1.00), p = 0.053). CONCLUSION: In unselected patients with acromegaly, the long-term biochemical control rate remains modest. Our findings indicate a need to identify patients at an earlier stage and improve therapeutic methods and surgical outcomes.
引用
- Falch CM, Dupont AK, Olarescu NC, et al. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway. Acta Neurochir (Wien). 2023. PMID: 37665404. doi:10.1007/s00701-023-05772-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。